Erlotinib
Overview
Categories
- 8 Antineoplastics, immunomodulators and drugs used in palliative care
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Erlotinib's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 100 mg | 100 (100) | 24 hourly | oral | For non-small cell PANCREATIC cancer, should be taken at least one hour before or two hours after the ingestion of food. |
| 150 mg | 150 (150) | 24 hourly | PO | For non-small cell LUNG cancer, should be taken at least one hour before or two hours after the ingestion of food. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Erlotinib is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Erlotinib is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Erlotinib
Back to top
Previous Drug Generic - Next Drug Generic